Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 2

Effects of an Antioxidant Supplement on Blood Vessel Health

University of Georgia · NCT06424756

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–75 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 2
Target enrollment
60
US sites recruiting
1
Study start
July 1, 2024
Record last updated
December 9, 2024

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide, and the non-Hispanic Black (NHB) population is disproportionately affected. Our research has previously demonstrated that oxidative stress may contribute to reduced vascular function in otherwise healthy NHB adults, potentially predisposing them to the development of hypertension and CVD. This study is designed to examine whether the mitochondria are an important source of oxidative stress-induced vascular dysfunction in healthy NHB adults.

Being studied: MitoQ; Placebo; MitoTempo; Tempol; L-NAME; SNP - Sodium Nitroprusside

Conditions: Healthy

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Self-identify as either non-Hispanic Black or non-Hispanic White.
  • Men and women 18-75 years old.
  • Non-hypertensive (systolic blood pressure [SBP]\<130 and diastolic blood pressure [DBP] \<85 mmHg).
  • Have low density lipoprotein cholesterol \<150mg/dl.
  • Have HbA1C \<6.0%.

Exclusion Criteria

  • Rash, skin disease, or disorders of pigmentation (e.g., psoriasis, eczema, vitiligo, or other skin inflammatory skin disorders)
  • Known skin allergies to latex or adhesives
  • Smoking and/or use of nicotine-containing products within the past year
  • Use of illegal/recreational drugs
  • Generalized kidney disease
  • Taking chloramphenicol, cholestyramine, medication for seizures, methotrexate, nitrofurantoin, tetracycline, barbiturates, steroids, phenobarbital/phenytoin, orlistat or pyrimethamine
  • Any current medications which could conceivably alter the cardiovascular control or responses
  • Diagnosed or suspected metabolic or cardiovascular disease
  • Current pregnancy or breastfeeding
  • History of skin or other cancers
  • Diagnosed or suspected diabetes (HbA1c ≥6.0)
  • Anybody with narcolepsy or who has been diagnosed with any condition that impairs body temperature regulation.

Recruiting US locations

  • Ramsey Student Center, University of Georgia

    Athens, GA 30602

Study contacts (from the official record)

  • S. Tony Wolf · 706-542-4378 · stwolf@uga.edu
  • Melissa Gorejena · mgorejena@uga.edu
All heart & blood pressure studies in Georgia →
Effects of an Antioxidant Supplement on Blood Vessel Health (NCT06424756) | Bored Studies